Visage Achieves Authority to Operate (ATO) from the U.S. Department of Veterans Affairs
Visage receives ATO for the Veterans Affairs Enterprise Cloud (VAEC)
SAN DIEGO, Sept. 4, 2025 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it has been granted an Authority to Operate (ATO) for the Veterans Affairs Enterprise Cloud (VAEC), by the U.S. Department of Veterans Affairs, for Visage 7 | CloudPACS, the cloud-based implementation of the Visage 7 Enterprise Imaging Platform ("Visage 7").
By securing this Agency ATO, Visage has successfully demonstrated, documented, tested and validated rigorous Federal security controls. Achieving VAEC ATO is a significant, multi-year milestone in Visage Imaging's journey working with our customer and sponsor, VISN 23 (VA Midwest Health Care Network) and the Veterans Health Administration (VHA). VISN 23 serves more than 440,000 enrolled Veterans residing in the states of Iowa, Minnesota, Nebraska, North Dakota, South Dakota and portions of Illinois, Kansas, Missouri, Wisconsin and Wyoming.
"We are honored to work with VISN 23 and the VA on their journey to the cloud. Moving Visage 7 to the VAEC will significantly benefit U.S. Veterans with even better performance, reliability, security and scale of their PACS and Enterprise Imaging," said Dr. Sam Hupert, CEO of Visage Imaging.
Visage exhibited last week at the 2025 Defense Health Information Technology Symposium (DHITS) in Nashville, TN. Visage 7 was demonstrated to federal health information technology physicians and professionals from the VHA and Defense Health Agency (DHA). For more information about Visage 7 | CloudPACS, click here.
About Visage Imaging, Inc.
A global provider of enterprise imaging solutions that enable PACS replacement with local, regional and national scale. The Visage 7 Enterprise Imaging Platform is proven, providing a fast, clinically rich, and highly scalable growth platform deliverable entirely from the cloud (Visage 7 | CloudPACS). Visage 7 supports the simplicity of a One Viewer™ philosophy, that enables diagnostic, clinical, specialty, research, and mobile imaging workflows from a singular platform. Visage also offers modular scalability and future-proof flexibility with enterprise workflow (Visage 7 | Workflow), vendor-neutral archive (Visage 7 | Open Archive) and artificial intelligence (Visage 7 | AI) solutions, all 100% native. https://visageimaging.com
About Pro Medicus Limited
Pro Medicus Limited [ASX: PME] is Australia's leading imaging IT provider. Founded in 1983, the company provides a full range of integrated software products and services to hospital, imaging centers and health care groups worldwide. www.promed.com.au
Visage, Visage Imaging, Visage Ease Pro, Visage Ease, Visage Ease VP, Visage Chat, Live Connect, One Viewer, ANV, CloudPACS.com, Video Reports, Load Balancer, Deep Search and Deconstructed PACS are trademarks, registered trademarks and service marks that are licensed by Visage Imaging Inc. Other product and company names mentioned may be trademarks and/or registered trademarks of their respective owners or licensees.
View original content to download multimedia:https://www.prnewswire.com/news-releases/visage-achieves-authority-to-operate-ato-from-the-us-department-of-veterans-affairs-302546578.html
SOURCE Visage Imaging, Inc.
Ausgewählte Hebelprodukte auf Pingtan Marine Enterprise
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Pingtan Marine Enterprise
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Pingtan Marine Enterprise Aktie News
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Pingtan Marine Enterprise Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Pingtan Marine Enterprise nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
Keine Analysen gefunden.
